Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Novartis
UBS
Chinese Patent Office
Federal Trade Commission
US Army
Daiichi Sankyo
Citi
Julphar
Cantor Fitzgerald

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,252,839

« Back to Dashboard

Which drugs does patent 7,252,839 protect, and when does it expire?

Patent 7,252,839 protects KYLEENA and SKYLA and is included in two NDAs.

This patent has thirty patent family members in twenty-six countries.
Summary for Patent: 7,252,839
Title:Delivery system and a manufacturing process of a delivery system
Abstract: A delivery system including a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, the capsule having at least a first end and a second end. The body construction (7, 12, 34) has at least two locking parts (9, 10), each locking part (9, 10) having at least a first end and a second end, the first end of each locking part (9, 10) having a surface adapted to face and cover one of the at least first and second ends of the capsule (8). The diameter of at least one of the locking parts varies along its length between the first end and the second end, and the capsule (8) is mounted between the at least two locking parts. Also disclosed is a manufacturing process of a delivery system, the system including a body construction and at least one capsule containing a pharmaceutical composition.
Inventor(s): Hallinen; Esa (Lempaala{umlaut over ( )}, FI), Lyytikainen; Heikki (Naantali, FI), Jarvela; Pentti (Lahti, FI), Kivi; Ilkka (Pirkkala, FI)
Assignee: Schering Oy (Turku, FI)
Application Number:10/528,237
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Process;

Drugs Protected by US Patent 7,252,839

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare KYLEENA levonorgestrel INTRAUTERINE DEVICE;INTRAUTERINE 208224-001 Sep 16, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Bayer Hlthcare SKYLA levonorgestrel INTRAUTERINE DEVICE;INTRAUTERINE 203159-001 Jan 9, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,252,839

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
02020869Sep 18, 2002
PCT Information
PCT FiledSeptember 04, 2003PCT Application Number:PCT/FI03/00647
PCT Publication Date:April 01, 2004PCT Publication Number: WO2004/026196

International Patents Family Members for US Patent 7,252,839

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland 214245 ➤ Sign Up
Poland 374112 ➤ Sign Up
New Zealand 538275 ➤ Sign Up
Norway 331466 ➤ Sign Up
Norway 20051858 ➤ Sign Up
Mexico PA05002718 ➤ Sign Up
South Korea 100827635 ➤ Sign Up
South Korea 20050057381 ➤ Sign Up
Japan 4382668 ➤ Sign Up
Japan 2005538791 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cipla
Chubb
Merck
QuintilesIMS
Baxter
Deloitte
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot